Cholangitis primary prevention

	Cholangitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cholangitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cholangitis primary prevention On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cholangitis primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cholangitis primary prevention
CDC on Cholangitis primary prevention
Cholangitis primary prevention in the news
Blogs on Cholangitis primary prevention
Directions to Hospitals Treating Cholangitis
Risk calculators and risk factors for Cholangitis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farwa Haideri [2]

Overview

Although reestablishing biliary drainage is the main focus of treatment, antibiotics play an important role in the management of cholangitis.

There are no established measures for the primary prevention of cholangitis in otherwise healthy people.
Treatment of gallstones, tumors, and infestations of parasites may reduce the risk for some people.
Patients undergoing ERCP should have prophylactic antibiotics.

Patients with compromised biliary systems prone to developing recurrent cholangitis may benefit from antibiotic maintenance therapy, given daily in lower-than-therapeutic dosages^[1]